Mineralys Therapeutics (MLYS) Amortizatization of Intangibles (2022 - 2026)

Mineralys Therapeutics (MLYS) has 5 years of Amortizatization of Intangibles data on file, last reported at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles rose 342.16% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $13.5 million (up 69.45% YoY), and the FY2025 full-year result was $9.9 million, up 5.04% from the prior year.
• Amortizatization of Intangibles improved to $4.6 million in Q1 2026, from $4.2 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $4.6 million in Q1 2026 to a low of $239000.0 in Q3 2022.
• A 5-year average of $2.1 million and a median of $2.1 million in 2023 frame the typical range for Amortizatization of Intangibles.
• Across the five-year window, Amortizatization of Intangibles surged 720.92% in 2023 and slumped 58.31% in 2025, its largest moves.
• Tracing MLYS's Amortizatization of Intangibles over 5 years: stood at $410000.0 in 2022, then jumped by 403.9% to $2.1 million in 2023, then plunged by 35.29% to $1.3 million in 2024, then soared by 214.73% to $4.2 million in 2025, then grew by 9.91% to $4.6 million in 2026.
• Business Quant data shows MLYS's Amortizatization of Intangibles at $4.6 million in Q1 2026, $4.2 million in Q4 2025, and $2.4 million in Q3 2025.